Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).

ABSTRACT:

SUBMITTER: Ye Q 

PROVIDER: S-EPMC7290137 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature